What I’m Testing
Completed Protocols
GHK-Cu (Copper Peptide) Completed
GHK-Cu is a naturally occurring copper-binding peptide that has attracted attention for its potential role in skin health, tissue repair, collagen production, and healthy aging. Some researchers also investigate its possible effects on hair quality, inflammation, and recovery processes.
BPC-157 Completed
- June 18–26: 500 mcg daily (oral capsules)
- From June 27: 500 mcg twice daily (morning and evening)
BPC-157 is being studied for its potential effects on tissue healing, gut health, recovery, and inflammation modulation. Although human data remain limited, it has become increasingly popular among athletes and biohackers interested in supporting recovery and resilience.
Current Protocols
Glow Blend
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg
Glow is a peptide blend combining GHK-Cu, BPC-157, and TB-500. It is being explored for its potential role in skin quality, collagen production, tissue repair, recovery, and connective tissue health. This protocol aims to compare the effects of the combination with those observed when testing the individual peptides separately.
KPV
KPV is a small peptide fragment derived from α-MSH that is currently being investigated for its potential anti-inflammatory effects. Research is exploring its possible role in gut health, skin conditions, immune regulation, and recovery from chronic inflammation.
Future Plans
MOTS-c
A mitochondrial-derived peptide currently being investigated for its potential effects on metabolic flexibility, insulin sensitivity, exercise performance, and cellular energy production.
NAD+
NAD+ plays a central role in cellular energy metabolism and mitochondrial function. This protocol will explore its potential effects on energy levels, recovery, cognitive performance, and healthy aging.
Epitalon
Epitalon is a synthetic peptide being studied for its potential influence on melatonin regulation, sleep, cellular aging, and healthy longevity. Human evidence remains limited.
Retatrutide
A next-generation triple agonist currently under investigation for obesity and metabolic disease. Given my current body composition (~16% body fat), I have not yet decided whether testing it would be appropriate, beneficial, or potentially too risky.
Everything described on this page reflects my personal self-experimentation journey and does not constitute medical advice.
Over the coming months, I will share detailed updates, experiences, and observations through dedicated videos on TikTok and other platforms.
All protocols are conducted under medical supervision, with regular health monitoring that includes blood work, advanced body composition analyses (BIA), and other assessments when appropriate. I will discuss these results and methodologies in more detail as the project evolves.
My goal is simple: to approach longevity with curiosity, transparency, and a commitment to collecting objective data rather than relying solely on anecdotes or trends.